Open main menu
Home
Random
Recent changes
Special pages
Community portal
Settings
About Consumerium development wiki
Disclaimers
Consumerium development wiki
Search
User menu
Talk
Contributions
Log in
Editing
User:Jukeboksi/Wiki.study/Natural therapeutics
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== CBG ==== [[w:Cannabigerol|Cannabigerol]] {{Q|Cannabigerol has been shown to promote [[w:apoptosis|apoptosis]] in cancer cells and inhibit tumor growth in mice. It acts as an [[w:a2-adrenergic receptor|Ξ±<sub>2</sub>-adrenergic receptor]] agonist, [[w:5-HT1A receptor|5-HT<sub>1A</sub> receptor]] antagonist, and CB<sub>1</sub> receptor antagonist.<ref name="pmid20002104">{{cite journal|doi=10.1111/j.1476-5381.2009.00515.x |title=Evidence that the plant cannabinoid cannabigerol is a highly potent Ξ±2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist |year=2010 |last1=Cascio |first1=MG |last2=Gauson |first2=LA |last3=Stevenson |first3=LA |last4=Ross |first4=RA |last5=Pertwee |first5=RG |journal=British Journal of Pharmacology |volume=159 |pages=129β41 |pmid=20002104 |issue=1 |pmc=2823359}}</ref> It also binds to the CB<sub>2</sub> receptor.<ref name="pmid20002104" />|Wikipedia|[[w:Cannabinoid#Cannabigerol|Cannabigerol]]}} ''' Links about CBG ''' * https://comparecbd.com/cbg/
Summary:
Please note that all contributions to Consumerium development wiki are considered to be released under the GNU Free Documentation License 1.3 or later (see
Consumerium:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
To protect the wiki against automated edit spam, we kindly ask you to solve the following CAPTCHA:
Cancel
Editing help
(opens in new window)